NeuroSigma’s Monarch eTNS System for Epilepsy, Depression Cleared in Europe

NeuroSigma has obtained European approval for its Monarch external Trigeminal Nerve Stimulation (eTNS) system. The Monarch is indicated as an adjunctive treatment of epilepsy and major depressive disorder for patients more than 9 years of age.
MedGadget